NORWOOD, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (CRBP), a clinical-stage company focused on oncology and obesity, today announced the initiation of the multiple ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback